These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. [Severe hypertriglyceridemia in pregnancy. A clinical case report]. Perrone G; Critelli C Minerva Ginecol; 1996 Dec; 48(12):573-6. PubMed ID: 9026753 [TBL] [Abstract][Full Text] [Related]
52. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting. Millett F; Sielski J; Stoll H; Alston N; Gail S PA J; 1976; 6(2):54-9. PubMed ID: 10235781 [No Abstract] [Full Text] [Related]
53. Dyslipidemia in the era of HIV protease inhibitors. Stein JH Prog Cardiovasc Dis; 2003; 45(4):293-304. PubMed ID: 12638093 [TBL] [Abstract][Full Text] [Related]
54. Dyslipidemia in type 2 diabetes. Krauss RM; Siri PW Med Clin North Am; 2004 Jul; 88(4):897-909, x. PubMed ID: 15308384 [TBL] [Abstract][Full Text] [Related]
55. [School-seminar "New Diagnostic and Therapeutic Technology in Lipidology]. Geronina SA; Manasova PA Vopr Pitan; 2001; 70(5):46-7. PubMed ID: 11715700 [No Abstract] [Full Text] [Related]
56. [Treatment of dyslipidemias and its benefits]. Taskinen MR Duodecim; 1999; 115(10):1138-44. PubMed ID: 11877853 [No Abstract] [Full Text] [Related]
58. Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome. Després JP; Lemieux I; Pascot A; Alméras N; Dumont M; Nadeau A; Bergeron J; Prud'homme D Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):702-3. PubMed ID: 12692010 [No Abstract] [Full Text] [Related]
59. Niacin-based therapy for dyslipidemia: past evidence and future advances. Ito MK Am J Manag Care; 2002 Sep; 8(12 Suppl):S315-22. PubMed ID: 12240703 [TBL] [Abstract][Full Text] [Related]
60. [Drug therapy of dyslipidemias]. Fonda M; Cattin L; Guarnieri G Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]